Merck Receives CHMP Positive Opinion for Fertility Treatment

Merck & Co. Inc. announced the Committee for Medicinal Products for Human Use, or CHMP, of the European Medicines Agency has recommended approval of ELONVA, or corifollitropin alfa injection, as a treatment in controlled ovarian stimulation in combination with a GnRH antagonist.
RTTNews